1. United States Government Accounting Office. New drug development: science, business, regulatory and intellectual property issues cited as hampering drug development efforts. GAO-07-49, a report to congressional requesters. November 2006. Available at: http:// www.gao.gov/new.items/d0749.pdf. Accessed January 20, 2007.
2. Glass KC, Waring D. The physician/investigator’s obligation to patients participating in research: the case of placebo controlled trials. J Law Med Ethics 2005;33: 575–585.
3. Getz, KA. Forgotten voices in the transparency debate: online trial registries alone will not succeed at rebuilding public confidence. Appl Clin Trials 2006 April. Available at: http://www. actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id= 316473. Accessed May 22, 2007.
4. Gullo, K. New survey shows public perception of opportunity to participate in clinical trials has decreased slightly from last year. Harris Interactive Healthcare News 2005;5(6): 1–14. Available at: http://www.harrisinteractive.com/news/newsletters/healthnews/ HI_HealthCareNews2005Vol5_lss06.pdf.
5. Fox, M. Michael’s mission [Dateline Interview with Katie Couric]. April 16, 2006. Available at: http://www.michaeljfox. org/newsEvents_michaelInTheNews_article.cfm?ID = 28. Accessed January 20, 2007.